Hand transplantation and vascularized composite tissue allografts in orthopaedics and traumatology

Orthopaedics and Traumatology: Surgery and Research

Volumn 96, Issue 3, 2010, Pages 283-290

  Schuind, F ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Composite tissue allografts Transplantation; Hand transplantation

Indexed keywords

COMPOSITE GRAFT; FUNCTIONAL STATUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAND TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORTHOPEDIC SURGERY; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HAND; HUMANS; ORTHOPEDICS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; TRAUMATOLOGY;

EID: 77951977822     PISSN: 18770568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otsr.2010.03.003     Document Type: Review

References (132)

1. Black K.S., Hewitt C.W., Howard E.B., Fraser L.A., Mah B.J., et al. Diagnosis of rejection and functional analysis of composite tissue and skin allografts prolonged with cyclosporine. Transplantation Proceedings 15 (1983) 3069-3072
2. Siemionow M., and Ozer K. Advances in composite tissue allograft transplantation as related to the hand and upper extremity, clinical perspective. The Journal of Hand Surgery 27A (2002) 565-580
3. Barker J.H., Francois C.G., Frank J.M., and Maldonado C. Composite tissue allotransplantation. Transplantation 15 (2002) 832-835
4. Doi K. Homotransplantation of limbs in rats. A preliminary report on an experimental study with non-specific immunosuppressive drugs. Plastic and Reconstructive Surgery 64 (1979) 613-621
5. Siemionow M., Ortak T., Izycki D., Oke R., Cunningham B., Prajapati, et al. Induction of tolerance in composite-tissue allografts. Transplantation 74 (2002) 1211-1217
6. Lee W.P.A., and Mathes D.W. Hand transplantation: pertinent data and future outlook. The Journal of Hand Surgery 24A (1999) 906-9013
7. Guzman-Stein G., and Shons A.R. Functional recovery in the rat limb transplant model: a preliminary study. Transplantation Proceedings 19 (1987) 1115-1117
8. Halloran P.F., Bushuk M., and Stewart J.A. Effect of cyclosporine on the healing of vascularized and nonvascularized bone allografts in rodents. Transplantation Proceedings 15 (1983) 3053-3056
9. Hotokebuchi T., Arai K., Arita C., Miyahara H., Sugioka Y., and Kaibara N. Limb allografts in skeletally immature rats with cyclosporine: behavior of the growth plate. Transplantation Proceedings 21 (1989) 3183-3185
10. Hotokebuchi T., Arai K., Takagishi K., Arita C., Sugioka Y., and Kaibara N. Limb allografts in rats immunosuppressed with cyclosporine: as a whole-joint allograft. Plastic and Reconstructive Surgery 83 (1989) 1027-1036
11. Zuker RM. Lower extremity transplantation. Microneurovascular repairs and muscle function. Presentation at the 6th Composite Tissue Allotransplantation Symposium, Tucson, AZ, USA, 2006.
12. Schwind J.V. Successful transplantation of a leg in albino rats with reestablishment of muscular control. Science 84 2181 (1936) 355
13. Schwind J.V. Homotransplantation of extremities by parabiosis. Annals of the New York Academy of Sciences 99 (1962) 933-942
14. Schwind J.V. Homotransplantation of extremities of rats. Radiology 78 (1962) 806-809
15. Arai K., Hotokebuchi T., Miyahara H., Arita C., Mohtai M., Sugioka Y., et al. Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival. Transplantation 48 (1989) 782-786
16. Benhaim P., Anthony J.P., Lin L.Y.T., McCalmont T.H., and Mathes S.J. A long-term study of allogeneic rat hindlimb transplants immunosuppressed with RS-61443. Transplantation 56 (1993) 911-917
17. Black K.S., Hewitt C.W., Fraser L.A., Osborne J.G., Achauer B.M., Martin D.C., et al. Cosmos and Damian in the laboratory. The New England Journal of Medicine 306 (1982) 368-369
18. Black K.S., Hewitt C.W., Hwang J.S., Borger R.W., and Achauer B.M. Dose response of cyclosporine-treated composite tissue allografts in a strong histoincompatible rat model. Transplantation Proceedings 20 Suppl. 2 (1988) 266-268
19. Büttemeyer R., Jones N.F., Min Z., and Rao U. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plastic and Reconstructive Surgery 97 (1996) 139-148
20. Daniel R.K., Egerszegi E.P., Samulack D.D., Skanes S.E., Dykes R.W., and Rennie W.R.J. Tissue transplants in primates for upper extremity reconstruction: a preliminary report. The Journal of Hand Surgery 11A (1986) 1-8
21. Furnas D.W., Black K.S., Hewitt C.W., Fraser L.A., and Achauer B.M. Cyclosporine and long-term survival of composite tissue allografts (limb transplants) in rats (with historical notes on the role of plastic surgeons in allotransplantation). Transplantation Proceedings 15 Suppl. 1 (1983) 3063-3068
22. Herndon J.H. Composite tissue transplantation - a new frontier. The New England Journal of Medicine 343 (2000) 503-505
23. Hewitt C.W., Black K.S., Fraser L.A., Osborne J.G., Sayles T.J., Achauer B.M., et al. Cyclosporine-A is superior to prior donor-specific blood transfusion for the extensive prolongation of rat limb allograft survival. Transplantation Proceedings 15 (1983) 514-517
24. Hewitt C.W., Black K.S., Fraser L.A., Howard E.B., Martin D.C., Achauer B.M., et al. Composite tissue (limb) allografts in rats. I. Dose-dependent increase in survival with cyclosporine. Transplantation 39 (1985) 360-364
25. Hewitt C.W., Black K.S., Dowdy S.F., Gonzalez G.A., Achauer B.M., Martin D.C., et al. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation 41 (1986) 39-43
26. Hewitt C.W., Puglisi R.N., and Black K.S. Current state of composite tissue and limb allotransplantation: do present data justify clinical application?. Transplantation Proceedings 27 (1995) 1414-1415
27. Hovius S.E.R., Stevens H.P.J.D., van Nierop P.W.M., Rating W., van Strik R., and van der Meulen J.C. Allogeneic transplantation of the radial side of the hand in the rhesus monkey. I. Technical aspects. Plastic and Reconstructive Surgery 89 (1992) 700-709
28. Jones J.W., Üstüner E.T., Zdichavsky M., Edelstein J., Ren X., Maldonado C., et al. Long-term survival of an extremity composite tissue allograft with FK-506-mycophenolate mofetil therapy. Surgery 126 (1999) 384-388
29. Jones N.F. Concerns about human hand transplantation in the 21st century. The Journal of Hand Surgery 27A (2002) 771-787
30. Kann B.R., and Hewitt C.W. Composite tissue (hand) allotransplantation: are we ready? Editorial. Plastic and Reconstructive Surgery 107 (2001) 1060-1065
31. Lance E.M., Inglis A.E., Figarola F., and Veith F.J. Transplantation of canine hind limb. Surgical technique and methods of immunosuppression for allotransplantation. A preliminary report. Journal of Bone and Joint Surgery 53A (1971) 1137-1149
32. Lee W.P.A., Pan Y.C., Kesmarky S., Randolph M.A., Fiala T.S., Amarante M.T.J., et al. Experimental orthotopic transplantation of vascularized skeletal allografts: functional assessment and long-term survival. Plastic and Reconstructive Surgery 95 (1995) 336-349
33. Lipson R.A., Kawano H., Halloran P.F., McKee N.H., Pritzker K.P.H., and Langer F. Vascularized limb transplantation in the rat. I. Results with syngeneic grafts. Transplantation 35 (1983) 299
34. Lipson R.A., Kawano H., Halloran P.F., Pritzker K.P.H., Kandel R., and Langer F. Vascularized limb transplantation in the rat. II. Results with allogeneic grafts. Transplantation 35 (1983) 300-304
35. Llull R., Beko K.R., Black K.S., and Hewit C.W. Composite tissue allotransplantation: perspectives concerning eventual clinical exploitation. Transplantation Reviews 6 (1992) 175-188
36. Llull R., Murase N., Ye Q., Manez R., Demetris A.J., and Fournier V. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host-reaction. Transplantation Proceedings 27 (1995) 164-165
37. Muramatsu K., Doi K., Akino T., Shigetomi M., and Kawai S. Longer survival of rat limb allograft. Combined immunosuppression of FK-506 and 15-deoxyspergualin. Acta Orthopaedica Scandinavica 68 (1997) 581-585
38. Nolan L.M., and Bowen V. Extremity transplantation: a review of its current state of development. The Journal of Hand Surgery 18A (1993) 153-159
39. Poole M., Bowen J.E., and Batchelor J.R. Prolonged survival of rat leg allografts due to immunological enhancement. Transplantation 22 (1976) 108-1011
40. Porter B.B., and Lance E.M. Limb and joint transplantation. A review of research and clinical experience. Clinical Orthopaedics and Related Research 104 (1974) 249-274
41. Press B.H.J., Sibley R.K., and Shons A.R. Modification of experimental limb allograft rejection with cyclosporine and prednisone: a preliminary report. Transplantation Proceedings 15 Suppl. 1 (1983) 3057-3062
42. Samulack D.D., Dykes R.W., and Munger B.L. Neurophysiologic aspects of allogeneic skin and upper extremity composite tissue transplantation in primates. Transplantation Proceedings 20 Suppl. 2 (1988) 279-290
43. Siliski J.M., and Green C.J. More on Cosmas and Damian. The New England Journal of Medicine 309 (1982) 1642
44. Stark G.B., Swartz W.M., Narayanan K., and Moller A.R. Hand transplantation in baboons. Transplantation Proceedings 19 (1987) 3968-3971
45. Tamai S. Editorial - Reflections on human hand allografts. Journal of Orthopaedic Science 4 (1999) 325-327
46. Üstüner E.T., Zdichavsky M., Ren X., Edelstein J., Maldonado C., Ray M., et al. Long-term composite tissue allograft survival in a porcine model with cyclosporine/mycophenolate mofetil therapy. Transplantation 66 (1998) 1581-1587
47. van den Helder T.B.M., Benhaim P., Anthony J.P., McCalmont T.H., and Mathes S.J. Efficacy of RS-61443 in reversing acute rejection in a rat model of hindlimb allotransplantation. Transplantation 57 (1994) 427-433
48. Yeh L.S., Gregory C.R., Griffey S.M., Lecouter R.A., Hou S.M., and Morris R.E. Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat. Transplantation 64 (1997) 919-940
49. Lapchinsky A.G., Eingorn A.G., and Uratkov E.F. Homotransplantation of extremities in tolerant dogs observed up to seven years. Transplantation Proceedings 5 1 (1973) 773-779
50. Dubernard J.M., Owen E., Herzberg G., Lanzetta M., Martin X., and Kapila H. Human hand allograft: report on first 6 months. Lancet 353 (1999) 1315-1320
51. Dubernard J.M., Owen E., Herzberg G., Martin X., Guigal V., Dawahra M., et al. Première transplantation de main chez l'homme. Résultats précoces. Chirurgie 124 (1999) 358-367
52. Dubernard J.M., Henry P., Parmentier H., Vallet B., Vial D., and Badet L. Première transplantation des deux mains : résultats à 18 mois. Annales de Chirurgie 127 (2002) 19-25
53. Petruzzo P., Lanzetta M., Dubernard J.M., Margreiter R., Schuind F., Breidenbach W., et al. The international registry on hand and composite tissue transplantation. Transplantation 86 4 (2008) 487-492
54. Pei G. Hand transplant patients. Experience in China. Presentation at the 6th composite tissue allotransplantation symposium (2006), Tucson, AZ, USA
55. Schuind F., Van Holder C., Mouraux D., Robert Ch, Meyer A., Salvia P., et al. The first Belgian hand transplantation - 37-month term results. J Hand Surg Br 31 4 (2006) 371-376
56. Schneeberger S., Gorantla V.S., van Riet R.P., Lanzetta M., Vereecken P., van Holder C., et al. Atypical acute rejection after hand transplantation. American Journal of Transplantation 8 3 (2008) 688-696
57. Schuind F., Abramowicz D., and Schneeberger S. Hand transplantation: the state-of-the-art. The Journal of Hand Surgery European Volume 32 1 (2007) 2-17
58. Li Z., Benghiat F.S., Kubjak C., Schuind F., Goldman M., Le A., et al. Donor T-cell development in host thymus after heterotopic limb transplantation in mice. Transplantation 83 6 (2007) 815-818
59. Li Z, Benghiat FS, Charbonnier LM, Kubjak C, Rivas MN, Cobbold SP, Waldmann H, De Wilde V, Petein M, Schuind F, Goldman M, Le Moine A. CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice. American Journal of Transplantation 2008;8:2527-36.
60. Bachman D., and Burloux G. The psychatrist and the hand transplant. In: Dubernard J.M. (Ed). Composite Tissue Allografts (2001), John Libbey Eurotext, Paris 85-91
61. Chin K.R., Lonner J.H., Jupiter B.S., and Jupiter J.B. The surgeon as a hand patient: the clinical and psychological impact of hand and wrist fractures. The Journal of Hand Surgery 24A (1999) 59-63
62. Foucher G. Prospects for hand transplantation. Lancet 353 (1999) 1286-1287
63. Meyer T.M. Psychological aspects of mutilating hand injuries. Hand Clinics 19 (2003) 41-49
64. Schweitzer I., Rosenbaum M.B., Sharzer L.A., and Strauch B. Psychological reactions and processes following replantation surgery: a study of 50 patients. Plastic and Reconstructive Surgery 76 (1985) 97-103
65. Sims A.C.P. Psychogenic causes of physical symptoms, accidents and death. The Journal of Hand Surgery 10B (1985) 281-282
66. Guimberteau J.C., Baudet J., Panconi B., Boileau R., and Potaux L. Human allotransplant of a digital flexion system vascularized on the ulnar pedicle: a preliminary report and 1-year follow-up of two cases. Plastic and Reconstructive Surgery 89 6 (1992) 1135-1147
67. Bakhach J., Casoli V., and Guimberteau J.C. La cryopréservation de tissues composites : principes, revue de la literature et expérience de l'équipe bordelaise. Annales de Chirurgie Plastique et Esthetique 52 5 (2007) 531-547
68. Doi K., Kawai S., and Shigetomi M. Congenital tibial pseudoarthrosis treated with vascularised bone allograft. Lancet 347 9006 (1996) 970-971
69. Hofmann G.O., Kirschner M.H., Wagner F.D., Brauns L., Gonschorek O., and Bühren V. Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints: first clinical experiences. Transplantation Proceedings 30 (1998) 2754-2761
70. Hofmann G.O., and Kirschner M.H. Clinical experience in allogeneic vascularized bone and joint allografting. Microsurgery 20 (2000) 375-383
71. Diefenbeck M., Wagner F., Kirschner M.H., Nerlich A., Mückley T., and Hofmann G.O. Outcome of allogeneic vascularized knee transplants. Transplant International 20 5 (2007) 410-418
72. Shigetomi M., Doi K., Kuwata N., Muramatsu K., Yamamoto H., and Kawai S. Experimental study on vascularized bone allografts for reconstruction of massive bone defects. Microsurgery 15 9 (1994) 663-670
73. Ikeda K., Shigetomi M., Ihara K., Tsubone T., Hashimoto T., Kawano H., et al. Effects of cessation of immunosuppression on skeleton reconstructed by vascularized bone allograft in rats. Journal of Orthopaedic Research 22 2 (2004) 388-394
74. Doi K., Akino T., Shigetomi M., Muramatsu K., and Kawai S. Revascularized intercalary bone allografts with short-term immunosuppression with cyclosporine in the canine. Plastic and Reconstructive Surgery 101 3 (1998) 793-801
75. Jones T.R., Humphrey P.A., and Brennan D.C. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in renal transplant patient. Transplantation Proceedings 30 6 (1998) 2746-2753
76. Strome M., Stein J., Esclamado R., Hicks D., Lorenz R.R., Braun W., et al. Laryngeal transplantation and 40-month follow-up. The New England Journal of Medicine 344 22 (2001) 1676-1679
77. Duque E., Duque J., Nieves M., Mejía G., López B., and Tintinago L. Management of larynx and trachea donors. Transplantation Proceedings 39 7 (2007) 2076-2078
78. Dubernard J.M., Lengelé B., Morelon E., Testelin S., Badet L., Moure C., et al. Outcomes 18 months after the first human partial face transplantation. The New England Journal of Medicine 357 24 (2007) 2451-2460
79. Lantieri L., Meningaud J.P., Grimbert P., Bellivier F., Lefaucheur J.P., Ortonne N., et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study. Lancet 372 9639 (2008) 639-645
80. Levi D.M., Tzakis A.G., Kato T., Madariaga J., Mittal N.K., Nery J., et al. Transplantation of the abdominal wall. Lancet 361 9376 (2003) 2173-2176
81. Halloran P.F., Melk A., and Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. Journal of the American Society of Nephrology 10 (1999) 167-181
82. Kouwenhoven E.A., Ijzermans J.N.M., and de Bruin R.W.F. Etiology and pathophysiology of chronic transplant dysfunction. Transplantation International 13 (2000) 385-401
83. Nagano H., and Tilney N.L. Chronic allograft failure: the clinical problem. American Journal of the Medical Sciences 313 (1997) 305-309
84. Puyoo O., Rostaing L., Benard E., Cisterne J.M., Modesto A., and Durand D. Risk factors of chronic rejection after renal transplantation: retrospective study of 201 patients. Transplantation Proceedings 30 (1998) 2804-2806
85. Brenner M.J., Tung T.H., Jensen J.N., and Mackinnon S.E. The spectrum of complications of immunosuppression: is the time right for hand transplantation? Current concepts review. Journal of Bone and Joint Surgery 84A (2002) 1861-1870
86. Matas A. Chronic rejection in renal transplants. Risk factors and correlates. Clinical Transplantation 8 (1994) 332-335
87. Benhaim P., Anthony J.P., Ferreira L., Borsanyi J.P., and Mathes S.J. Use of combination of low-dose cyclosporine and RS-61443 in a rat hindlimb model of composite tissue allotransplantation. Transplantation 6 (1996) 527-532
88. Breidenbach III W.C., Tobin II G.R., Gorantla V.S., Gonzalez v., and Granger D.K. A position statement in support of hand transplantation. The Journal of Hand Surgery 27A (2002) 760-770
89. Daoud A.J., Schroeder T.J., Shah M., Hariharan S., Peddi V.R., Weiskittel P., et al. A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisolone and tacrolimus. Transplantation Proceedings 30 (1998) 4079-4081
90. Gorantla V.S., Barker J.H., Jones Jr. J.W., Maldonado C., and Granger D.K. Immunosuppressive agents used in transplantation: mechanisms of action and current antirejection strategies. Microsurgery 20 (2000) 420-429
91. Jones N.F., Hebebrand D., Buttemeyer R., Zhao M., Benhaim P., and Rao U. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation. Plastic and Reconstructive Surgery 107 (2001) 777-784
92. Kahan B.D., and Ghobrial R. Immunosuppressive agents. The Surgical Clinics of North America 74 (1994) 1029-1054
93. Lanzetta M., Nolli R., Borgonovo A., Owen E.R., Dubernard J.M., Kapila H., et al. Hand transplantation: ethics, immunosuppression and indications. The Journal of Hand Surgery 26B (2001) 511-516
94. Lanzetta M., Petruzzo P., Vitale G., Lucchina S., Owen E.R., and Dubernard J.M. Human hand transplantation: what have we learned?. Transplantation Proceedings 36 (2004) 664-668
95. Dummer J.S., Hardy A., Poorsattar A., and Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 36 (1983) 259-357
96. Fishman J.A., and Rubin R.H. Infection in organ-transplant recipients. The New England Journal of Medicine 338 (1998) 1741-1751
97. Lees V.C., and McCabe S.J. The rationale for hand transplantation. Transplantation 74 (2002) 749-753
98. Lee W.P.A. Composite tissue transplantation: more science and patience needed. Editorial. Plastic and Reconstructive Surgery 107 (2001) 1066-1070
99. Schneeberger S., Lucchina S., Lanzetta M., Brandacher G., Bosmuller C., Steurer W., et al. Cytomegalovirus-related complications in human hand transplantation. Transplantation 27 (2005) 441-447
100. First M.R., and Peddi V.R. Malignancies complicating organ transplantation. Transplantation Proceedings 30 (1998) 2768-2770
101. Penn I. Horizons in organ transplantation. Malignancy. The Surgical Clinics of North America 74 (1994) 1247-1257
102. Penn I. Posttransplant malignancies. Transplantation Proceedings 31 (1999) 1260-1262
103. Baumeister S., Kleist C., Döhler B., Bickert B., Germann G., and Opelz G. Risks of allogeneic hand transplantation. Microsurgery 24 (2004) 98-103
104. DiGiovanna J.J. Posttransplantation skin cancer: scope of the problem, management and role for systemic retinoid chemoprevention. Transplantation Proceedings 30 (1998) 2771-2775
105. Euvrard S., Kanitakis J., and Claudy A. Skin cancers after organ transplantation. The New England Journal of Medicine 348 (2003) 1681-1691
106. Ong C.S., Keogh A.M., Kossard S., Macdonald P.S., and Spratt P.M. Skin cancer in Australian heart transplant recipients. Journal of the American Academy of Dermatology 40 (1999) 27-34
107. Finn L., Reyes J., Bueno J., and Yunis E. Epstein-Barr virus infections in children after transplantation of the small intestine. American Journal of Surgical Pathology 22 (1998) 299-309
108. Preiksaitis J.K., and Keay S. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clinical Infectious Diseases 33 Suppl. 1 (2001) S38-S46
109. Dubernard J.M., Burloux G., Giraux P., Bachman D., Petruzzo P., and Kanitakis J. Trois enseignements de la première allogreffe des deux mains. Bulletin de l'Académie Nationale de Médecine 186 (2002) 1051-1065
110. Opelz G., and Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342 (1993) 1514-1516
111. Stallone G., Schena A., Infante B., Di Paolo S., Loverre A., Maggio G., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. The New England Journal of Medicine 352 (2005) 1317-1323
112. Pollard S. Hand transplantation. Risks of immunosuppression. Invited comment on hand transplantation. The Journal of Hand Surgery 26B (2001) 517
113. Granger D.K., Breidenbach W.C., Pidwell D.J., Jones J.W., Baxter-Lowe L.A., and Kaufman C.L. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation 74 (2002) 1624-1630
114. Hewitt C.W. Update and outline of the experimental problems facing clinical composite tissue transplantation. Transplantation Proceedings 30 (1998) 2704-2707
115. Petruzzo P., Revillard J.P., Kanitakis J., Lanzetta M., Hakim N., Lefrancois N., et al. First human double hand transplantation: efficacy of a conventional immunosuppressive protocol. Clinical Transplantation 17 (2003) 455-460
116. Elster E.A., Blair P.J., and Kirk A.D. Potential of costimulation-based therapies for composite tissue allotransplantation. Microsurgery 20 (2000) 430-434
117. Gorantla V.S., Prabhune K.A., Perez-Abadia G., Ildstad S.T., Maldonado C., Orhun H.I., et al. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease. Transplantation 75 (2003) 922-932
118. Hettiaratchy S. Transplantation tolerance and chimerism: what are they and do we need them?. Plastic and Reconstructive Surgery 113 (2004) 2213-2214
119. Llull R. An open proposal for clinical composite tissue allotransplantation. Transplantation Proceedings 30 (1998) 2692-2696
120. Orloff M.S., DeMara E.M., Coppage M.L., Leong N., Fallon M.A., and Sickel J. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation 59 (1995) 282-288
121. Ozer K., Oke R., Gurunluoglu R., Zielinski M., Izycki D., Prajapati R., et al. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment. Transplantation 75 (2003) 31-36
122. Rossini A.A., Greiner D.L., and Mordes J.P. Induction of immunologic tolerance for transplantation. Physiological Reviews 79 (1999) 99-141
123. Thomas F., Ray P., and Thomas J.M. Immunological tolerance as an adjunct to allogeneic tissue grafting. Microsurgery 20 (2000) 435-440
124. Werkele T., Sachs D.H., and Sykes M. Mixed chimerism for the induction of tolerance: potential applicability in clinical composite tissue grafting. Transplantation Proceedings 30 (1998) 2708-2710
125. Shapiro R., Ellis D., Tan H.P., Moritz M.L., Basu A., Vats A.N., et al. Alemtuzumab preconditioning with tacrolimus monotherapy in pediatric renal transplantation. American Journal of Transplantation 7 12 (2007) 2736-2738
126. Butler P.E.M., Lee W.P.A., van de Water A.P., and Randolph M.A. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression. Plastic and Reconstructive Surgery 105 (2000) 2424-2430
127. Petit F., Minns A.B., Nazzal J.A., Hettiaratchy S.P., Lantieri L.A., and Randolph M.A. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells. Plastic and Reconstructive Surgery 113 (2004) 270-276
128. Adams A.B., Pearson T.C., and Larsen C.P. Heterologous immunity: an overlooked barrier to tolerance. Immunological Reviews 196 (2003) 147-160
129. Barker J.H., Jones J.N., and Breidenbach W.C. Closing remarks. Transplantation Proceedings 30 (1998) 2787
130. Black K.S., Hewitt C.W., Fraser L.A., Howard E.B., Martin D.C., Achauer B.M., et al. Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine. Transplantation 39 (1985) 365-368
131. Foster R.D., Pham S., Li S., and Aitouche A. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation 76 (2003) 988-994
132. Mathes D.W., Randolph M.A., and Lee W.P.A. Strategies for tolerance induction to composite tissue allografts. Microsurgery 20 (2000) 448-452